PVCT · Provectus Biopharmaceuticals, Inc. · Documents
$0.05
+0.00 (+0.00%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The aforementioned factors indicate that management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.01M
Shares
420.28M
Volume · Oct 22
5211
Avg daily vol (3M)
118.31K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-07-01 | 2026-06-30 | |
| 8-K | — | 2026-06-22 | 2026-06-18 | |
| 8-K | — | 2026-06-18 | — | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| ARS | — | 2026-04-30 | 2025-12-31 | |
| DEF 14A | — | 2026-04-30 | — | |
| DEFA14A | — | 2026-04-30 | — | |
| 8-K | — | 2026-04-21 | 2026-04-20 | |
| PRE 14A | — | 2026-04-20 | — | |
| 10-K | — | 2026-03-26 | 2025-12-31 | |
| 8-K | — | 2026-02-02 | 2026-01-30 | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| 8-K | — | 2025-06-20 | 2025-06-18 | |
| 8-K | — | 2025-06-18 | — | |
| DEFA14A | — | 2025-06-18 | — | |
| 10-K/A | — | 2025-05-16 | 2024-12-31 | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| ARS | — | 2025-05-05 | 2024-12-31 | |
| DEFA14A | — | 2025-05-01 | — | |
| DEF 14A | — | 2025-05-01 | 2025-04-30 | |
| PRE 14A | — | 2025-04-18 | 2024-12-31 | |
| 8-K | — | 2025-04-16 | 2025-04-15 | |
| 10-K | — | 2025-03-28 | 2024-12-31 | |
| 8-K | — | 2025-01-22 | 2025-01-15 | |
| 8-K | — | 2024-12-26 | 2024-12-20 | |
| 8-K | — | 2024-12-11 | 2024-12-05 | |
| 8-K | — | 2024-12-05 | 2024-12-02 | |
| 8-K | — | 2024-11-14 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-08-19 | 2024-08-14 | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-07-17 | 2024-07-11 | |
| 8-K | — | 2024-06-25 | 2024-06-21 | |
| 8-K | — | 2024-06-21 | 2024-06-20 | |
| 8-K | — | 2024-06-20 | — | |
| DEFA14A | — | 2024-06-20 | — | |
| 10-Q | — | 2024-05-14 | 2024-03-31 | |
| ARS | — | 2024-05-09 | 2023-12-31 | |
| DEFA14A | — | 2024-05-06 | — | |
| DEF 14A | — | 2024-05-06 | — | |
| 10-K/A | — | 2024-04-29 | 2023-12-31 | |
| PRE 14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-16 | 2024-04-10 | |
| 10-K | — | 2024-03-28 | 2023-12-31 | |
| 8-K | — | 2024-03-27 | 2024-03-21 | |
| 8-K | — | 2024-03-26 | 2024-03-25 | |
| 8-K | — | 2024-02-22 | — | |
| 8-K | — | 2024-02-15 | — |
Showing 1–50 of 101 filings